Results 11 to 20 of about 1,560,419 (396)

Viral Vaccines

Reference Module in Biomedical Sciences, 2014
Since antiquity, humans have strived to find ways to prevent the suffering and mortality caused by infectious pathogens. No interventions in medical history have had a bigger impact on human health than the development of preventative vaccines against infectious diseases.
Viral Vaccines, M. Schleiss
openaire   +2 more sources

Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase [PDF]

Front Cell Infect Microbiol
BackgroundViral vaccines have been proven significant in protecting us against viral diseases such as COVID-19. To better understand and design viral vaccines, it is critical to systematically collect, annotate, and analyse various viral vaccines and ...
Huffman A, Gautam M, Gandhi A, Du P, Austin L, Roan K, Zheng J, He Y.   +7 more
europepmc   +2 more sources

60 Years of viral vaccines. [PDF]

Hum Vaccin Immunother, 2022
Wahren B.
europepmc   +5 more sources

Viral vaccines for farmed finfish [PDF]

VirusDisease, 2013
Over the past decade, aquaculture has grown at an average annual growth rate of approximately 6 % worldwide despite many challenges. Viral diseases are one of the major challenges that are threatening a sustainable growth of finfish farming globally.
Arun K. Dhar, F. C. Thomas Allnutt, Sanjib Kumar Manna   +2 more
openaire   +4 more sources

Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques. [PDF]

, 2012
Immunotherapies that induce durable immune control of chronic HIV infection may eliminate the need for life-long dependence on drugs. We investigated a DNA vaccine formulated with a novel genetic adjuvant that stimulates immune responses in the blood and
A Gallimore, A Kirmaier, A Watson, AA Lackner, AL Seman, AM Amedee, Amithi Narendran, Angela M. Amedee, AS von Gegerfelt, Brendon Wahlberg, Chen Liang, Cristy Stagnar, D Chen, D Verhoeven, DC Montefiori, Deborah Heydenburg Fuller, DH Barouch, DH Fuller, DH Fuller, DH Fuller, DH Fuller, E Rollman, E Tryniszewska, Eric J. Yager, EY Enioutina, EY Enioutina, Fiona C. Cook, GM Glenn, H Takeuchi, Heather Michael, HL Robinson, IM Belyakov, IM Belyakov, IM Belyakov, IM Belyakov, J Arrington, J Lisziewicz, J zur Megede, JD Boyer, Jenny W. Che, JJ Donnelly, JJ Kim, JM Brenchley, Joel R. Haynes, John Tite, JQ Wu, JR Haynes, Julia Nyaundi, JW Mellors, LA Knapp, LJ Berry, LN Martin, M Genesca, M Murphey-Corb, Michael Murphey-Corb, MR Betts, PA Mudd, Peter Ertl, Premeela Rajakumar, PT Loudon, R De Rose, R Taber, R Tubiana, RA Daynes, Rachel Taber, RR Amara, RS Veazey, RT Gandhi, S Staszewski, SA Riddler, SJ Kent, SJ Wilson, SY Lim, T Nakajima, TM Pertmer, TU Vogel, TW Chun, TW Chun, U Sauermann, W Lu, W Lu, WP Kong, X Wang, Y Levy, Z Hel   +84 more
core   +18 more sources

To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity

Viruses, 2021
Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030.
Felicia Schlotthauer, Joey McGregor, Heidi E Drummer   +2 more
doaj   +1 more source

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

Signal Transduction and Targeted Therapy, 2023
Human diseases, particularly infectious diseases and cancers, pose unprecedented challenges to public health security and the global economy.
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, N. Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang, X. Xia   +9 more
semanticscholar   +1 more source

Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines

Vaccines, 2022
New influenza strains are constantly emerging, causing seasonal epidemics and raising concerns to the risk of a new global pandemic. Since vaccination is an effective method to prevent the spread of the disease and reduce its severity, the development of
Zeyu Yang, Xingge Xu, Cristina A. T. Silva, Omar Farnos, Alina Venereo-Sanchez, Cécile Toussaint, Shantoshini Dash, Irene González-Domínguez, Alice Bernier, Olivier Henry, Amine Kamen   +10 more
doaj   +1 more source

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine

Vaccines, 2023
The administration of viral vectored vaccines remains one of the most effective ways to respond to the ongoing novel coronavirus disease 2019 (COVID-19) pandemic.
Zeyu Yang, Barbara Cristina Martins Fernandes Paes, Julia Puppin Chaves Fulber, Michelle Yen Tran, Omar Farnós, Amine A. Kamen   +5 more
doaj   +1 more source

Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.

The CRISPR Journal, 2021
CRISPR-Cas technology, discovered originally as a bacterial defense system, has been extensively repurposed as a powerful tool for genome editing for multiple applications in biology.
N. Tang, Yaoyao Zhang, Zhiqiang Shen, Yongxiu Yao, V. Nair   +4 more
semanticscholar   +1 more source